MedTrace Logo

Longvida Curcumin Human Pharmacokinetics Study

NCT03289507 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 9

Last updated 2023-02-08

No results posted yet for this study

Summary

The primary objective of the study is to characterize the curcumin metabolites of 2 different capsule formulations of curcumin relative to unformulated Curcuma longa extract of Rhizomes including assessing relative bioavailability and absorption/kinetic profile of curcumonoids and their metabolites in human plasma and urine after acute consumption.

Conditions

  • Healthy

Interventions

DIETARY_SUPPLEMENT

Treatment1

Longvida Capsule formulation A

DIETARY_SUPPLEMENT

Treatment2

Longvida Capsule formulation B

DIETARY_SUPPLEMENT

Treatment3

Curcuma longa extract of Rhizomes

Sponsors & Collaborators

  • Verdure Sciences

    collaborator INDUSTRY

  • Clinical Nutrition Research Center, Illinois Institute of Technology

    lead INDUSTRY

Principal Investigators

  • Britt M Burton-Freeman, Ph.D · Illinois Institute of Technology

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
QUADRUPLE
Model
CROSSOVER

Eligibility

Min Age
20 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-09-19
Primary Completion
2017-11-30
Completion
2018-01-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03289507 on ClinicalTrials.gov